Needham analyst Serge Belanger initiated coverage of Ocular Therapeutix (OCUL) with a Buy rating and $15 price target citing Axpaxli’s ...
As part of the campaign, NBK is raising awareness among customers about fraudulent schemes targeting Instant Payment Service (WAMD). The bank underscores the importance of recognizing these tactics ...